Rohto Pharmaceutical Co.,Ltd. provided dividend guidance of JPY 12.00 per share for the fiscal year ending March 31, 2024 as compared to paid dividend of JPY 12.00 per share a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,840 JPY | -1.66% | -9.81% | -0.19% |
04-04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
04-04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.19% | 4.37B | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- 4527 Stock
- News Rohto Pharmaceutical Co.,Ltd.
- Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024